SOUTH EASTERN TRUST. Point of Care Testing (POCT) Policy Ellie Duly, Chair POCT Committee. Approval date: Operational Date: November 2014
|
|
- David Stokes
- 5 years ago
- Views:
Transcription
1 Policy Code: SET/PtCtCare (186) 2014 SOUTH EASTERN TRUST Title: Author(s) Point of Care Testing (POCT) Policy Ellie Duly, Chair POCT Committee Ownership: Approval by: South Eastern Trust Ratified Directors as per signatory list December 2014 Approval date: Operational Next Date: Review: Version No. 3 Supercedes SET/PtCtCare (94) 2012 Links to other policies November 2014 December INTRODUCTION / PURPOSE OF POLICY 1.1 Point of Care Testing (POCT) refers to analytical tests undertaken by nonlaboratory staff outside a recognised diagnostic laboratory. These range from disposable hand-held strip readers to desktop analysers. 1.2 The Trust has an obligation to ensure that implementation of POCT conforms to current standards. The appropriate use of POCT as an alternative to central laboratory testing should be considered as a clinical governance issue and therefore be subject to examination of clinical effectiveness. Where possible, analytical investigations should be performed in clinical laboratories or other suitable environments by suitably trained and registered laboratory staff. Before deciding whether to implement POCT it is essential for potential users to establish a clinical need, including an examination as to whether reconfiguration of a central laboratory service would be a viable option. The clinical need should be evidence based, clearly identifying the risks and benefits of introducing a POCT service. 2.0 DEFINITIONS/SCOPE OF THE POLICY 2.1 To ensure the appropriate use of POCT systems, that the principles of best practice are followed and that demonstrable standards of testing are maintained. 2.2 The policy is applicable to all South Eastern Health and Social Care Trust staff, (excluding Down and Lisburn area which is managed by the Belfast trust,) who are involved with managing, procuring, training, performing tests or interpreting results produced by POCT systems. It also applies to POCT systems that are given to patients by Trust staff. Page 1 of 16
2 3.0 ROLES/RESPONSIBILITIES 3.1 Corporate Responsibility The Chief Executive is part of the Trust Executive Management Team. On behalf of the Trust Board, he carries overall responsibility for Risk Management, including the effective use of POCT systems within the Trust. Figure 1: Relationships of the POCT Committee within the SEHSCT 3.2 The Laboratory The Laboratory Director will appoint a multidisciplinary POCT Committee to Advise on the provision of POCT. The Laboratory Director will appoint a POCT Manager who, along with the Laboratory POCT Co-ordinators, and with assistance from the Laboratory Quality Co-ordinator and Quality Officers, will ensure that standards for POCT are maintained according to Trust POCT policy and Health and Safety Policies POCT aims to comply with the Standards for the Medical Laboratory and Additional Standards for POCT Facilities set by CPA (UK) Ltd, as well as ISO 22870: Point-of-care testing (POCT) Requirements for quality and competence. The details of the quality management system for POCT is documented in the POCT Quality Manual [POCT MAN-3]. 3.3 The POCT committee The POCT committee is responsible to the Chief Executive, through the Women & Acute Child Health Governance Meeting, which has ultimate responsibility for defining the scope of POCT, taking into consideration the clinical need for POCT, its financial implications, technical feasibility, and in ensuring that appropriate measures are in place to monitor the accuracy and quality of POCT and the ability of the organisation to fulfil the needs and requirements of the user. Page 2 of 16
3 3.3.2 The POCT committee will assist in evaluating, selecting and implementing POCT devices and systems both at Trust and Regional level. Performance criteria for POCT systems will include consideration of accuracy, correlation with laboratory method, precision, detection limits, interferences and practicability. The POCT committee is responsible for implementing the terms of reference listed in Appendix 1 and the Chair of the POCT committee will provide a quarterly report for discussion at the Women and Acute Child Health Governance Meeting. Minutes are stored in Q pulse The committee holds an annual management review. POCT MAN Service Managers 3.5 Staff Service managers have responsibility for the management of POCT devices within the specific area of their remit and control and for ensuring that this policy is fully implemented as part of the Trusts governance arrangements. They must ensure staff are competent and that all incidents involving medical devices are reported via the Trust Incident Reporting system, and also to the POCT Co-ordinators. Copies of risk assessments for the devices are held by the managers It is the responsibility of Trust staff to ensure that: They only use POCT systems if they have received appropriate training, as defined by the Laboratory POCT Manager/ Co-ordinators and that they are competent and authorised to do so. They follow procedures and protocols regarding the use and management of POCT systems. They report any defects, faults or near misses that involve POCT systems immediately and inform their line manger which may result in instrument being taken out of use. Such Incidents must be reported by the line manager via the Trust incident reporting system, and also to the POCT co-ordinators. Personal operator identification numbers/barcodes are only to be used by the individual to whom they are issued, who are then responsible for the result. Sharing of barcodes is not permissible and may be subject to disciplinary proceedings. Loss of personal operator identification numbers must be reported immediately to the laboratory POCT co- coordinators. Results from POCT devices are transmitted electronically or written in patient notes. 4.0 KEY POLICY PRINCIPLES An effective quality management system must be set up to ensure that POCT is carried out according to applicable National and International guidelines 1-11,23,24, including Clinical Pathology Accreditation (UK) Ltd (CPA) standards and additional Page 3 of 16
4 standards for POCT testing 12, as well as ISO 22870: Point-of-care testing (POCT) Requirements for quality and competence and Health & Safety policies The Trust management of POCT should be assessed as part of the Pathology accreditation process as carried out by CPA (UK) Ltd and UKAS. 4.2 The details of the quality management system will be recorded in the POCT Quality manual [POCT MAN-3]. 4.3 The Trust POCT service should be clinically and professionally lead by a senior member of laboratory staff. 4.4 A multidisciplinary POCT Committee must be formed within the Trust. The Trust POCT Committee should consist of the representatives from the laboratory and from other stakeholders for the use of POCT. The committee should appoint a Chairperson; ideally this should be the laboratory POCT clinical lead. The POCT Committee should be positioned within the Trust s management structure and report as such. A representative of the Trust s committee should attend and report to the Regional POCT committee meetings and to the Northern Ireland Pathology Network via the Regional Chair of POCT. A POCT Manager and Co-ordinators should be identified within the Trust to provide specialist knowledge and advice to the POCT Committee and users of POCT devices. This manager should have the authority to regulate and oversee the POCT quality management system. 4.5 Regular audit of POCT must form an integral part of any quality management system. 4.6 Trust specific POCT procedures, based upon those described above, should be commissioned and approved by the Trust s POCT Manager. 4.7 All requests for POCT equipment must be submitted to the POCT committee for approval with details of clinical need and assessment of outcomes including costs on the Proposal for New or Replacement Point of Care Testing Applications in the South Eastern Health & Social Care Trust Form (Appendix 2). The POCT committee should decide on the appropriateness of any request, the reliability and robustness of the equipment available, the interfacing requirements, the riskbenefit and cost-benefit analyses, quality assessment and compliance with Trust policies including infection control and COSHH 17. Advice should be sought from the Trust s Infection Control Team and POCT departmental leads. The approval process, as detailed in the Medical Devices & Equipment Procurement Form (Appendix 3), must be followed. POCT devices must be procured according to the Trust s standing financial Instructions in the Medical Devices Policy. 4.8 POCT must not be considered where a laboratory can provide a result in a timely manner appropriate to clinical need. 4.9 All POCT devices adopted must: Be evaluated and procured in collaboration with Trust POCT committee and the POCT manager to ensure satisfactory standards of performance and safety. Conform to the requirements of the In Vitro Diagnostics Directive 18. Align with laboratory-based methods, where possible and practical, in current practice in the Trust. Page 4 of 16
5 Where possible have connectivity to appropriate specification to allow central management of POCT devices and documentation of results. Be used in accordance with manufacturer s or suppliers instructions. Be registered by serial number and decommissioned following laboratory guidelines Be subject to regular maintenance as specified by the supplying manufacturer. Have details of maintenance performed, faults and corrective action taken, documented. Only be used for the purpose for which it has been evaluated All POCT must be enrolled in an External Quality Assurance scheme (if available), or, if this is impractical, arrangements for parallel testing with the local laboratory should be considered. Internal Quality Control must be performed according to the test specific Standard Operating Procedure (SOP) Where possible and practical electronic devices rather than devices requiring a subjective visual read by the user should be used (it is recommended that where such visual read devices are in use, the results are checked by at least two trained members of staff) Where possible IT Connectivity should be made available and resourced to appropriate specification to allow central management of POCT devices and documentation of results in accordance with robust quality management. The Trust has recently procured Conworx IT system 4.13 If a device or part of a device is an ICT asset, or relies on ICT infrastructure, it should be procured in line with ICT procurement guidelines. It should adhere to minimum technical requirements as appropriate, particularly with regards to patching/antivirus/wireless specification, and meet relevant security requirements in accordance with all local, regional and other applicable policies Device specific Standard Operating Procedures (SOPs) must be developed by laboratory staff, and made available to all POCT users Only trained, certified and competent staff should use POCT equipment. Where possible such equipment should be password-protected and only accessible to trained/certified users. Passwords are unique to each trained operator, and must not be used by any other member of staff All patient and quality control testing results must be recorded. Patient results must be recorded in such detail as to allow unequivocal patient identification, the result, date and time of analysis and the name of the analyst. This record must be in addition to records made in the patient notes, and where available should be electronic. Such records should be kept according to guidelines issued by the RCPath All reagent/cartridge/consumable lot numbers must be recorded to facilitate patient tracking in the event of product recall All adverse events relating to POCT must be reported back to the POCT Committee through the IR1 system, which must have the authority to withdraw or suspend service in the event of a safety-related or performance issue or lack of Page 5 of 16
6 clinical or cost effectiveness. The committee should report any such issues to the Regional POCT Committee and NIAIC All staff who recommend the use of POCT systems or devices for use by patients must ensure that the devices have been approved by the Trust POCT committee or by the NI Regional POCT committee. 5.0 IMPLEMENTATION OF POLICY 5.1 Dissemination This policy has relevance to a wide group of staff including Medical, Nursing, Auxiliary Healthcare assistants, ambulance, Laboratory, Pharmacy, Procurement and Infection Control. It is the responsibility of managers and supervisors to ensure that this policy has been brought to the attention of all relevant staff who are then responsible for complying with its contents. 5.2 Resources POCT Co- ordinators will assist the commercial companies in ensuring staff are trained. Service managers or their delegated staff must ensure competencies are assessed and maintained. Up-to-date SOPs provided by POCT co- coordinators will be available to all staff via iconnect (Hospital Services Laboratories POCT Useful Documents). These should include all aspects of testing including quality control. 5.3 Exceptions All POCT devices in the Trust, excluding Downe and Lisburn area, are subject to the policy. 6.0 MONITORING Regular audits of POCT devices are a vital part of the POCT Quality Management System. The audits will be carried out in order to ensure processes are being carried out in line with operating procedures and that the procedures meet national requirements/standards (CPA/UKAS). 7.0 EVIDENCE BASE / REFERENCES 1. Point of Care Testing (Near Patient Testing) Guidance on the Involvement of the Clinical Laboratory, Institute of Biomedical Science, Device Bulletin DB2010 (02) Management and Use of IVD Point of Care Test Devices, February MHRA 3. Guidelines for point-of-care testing: Haematology. British Journal of Haematology 2008; 142: Guidelines on point-of-care testing. Royal College of Pathologists Code of practice for clinical biochemists/chemical pathologists POCT March Guidelines for Safe and Effective Management and Use of Point of Care Testing. Academy of Medical Laboratory Science, Association of Clinical Page 6 of 16
7 Biochemists in Ireland, Irish Medicines Board and RCPI Faculty of Pathology. November, Price CP, St John A, Hicks JM. Point of Care Testing, Washington, DC: AACC Press, 2nd edition BS EN ISO 22870:2006 Point of Care Testing Requirements for Quality and Competence. 8. BS EN ISO 15189:2007 Medical laboratories Particular requirements for quality and competence. 9. Depart Department of Health (1999) Clinical Governance: in the New NHS. Department of Health (Health Service Circular: HSC (99) 065), London. 10. Clinical Governance of NHS Staff in Single-Handed Practice with Particular Reference to Point-of-Care Testing. The Royal College of Pathologists, Health Professions Order 2001 Consolidated text incorporating repeals and amendments made up to 1st July Available from Clinical Pathology Accreditation (UK) Ltd (Version 2.02 Nov 2010) Standards for the Medical Laboratory. CPA Ltd, Sheffield, UK., Additional standards for Point of Care testing (POCT) (Version 1.01 Nov 2010) 13. Health and Safety at Work Order Department of Health Advisory Committee on Dangerous Pathogens (2003) Infection at work controlling the risk. Department of Health, London. 15. Biological Agents: Managing the risks in laboratories and healthcare premises. HSE / ACDP Health Services Advisory Committee (2003) Safe working and the prevention of infection in clinical laboratories and similar facilities. Health and Safety Executive, ISBN HSE Books, Sudbury. 17. Health and Safety Executive, Control of Substances Hazardous to Health (COSHH) 2002 (as amended ) Fifth edition ) 2005 Approved Code of practice and Guidance 18. In-vitro Diagnostics Medical Devices Directive 98/79/EC. 19. Royal College of Pathologists and Institute of Biomedical Science. The Retention and Storage of Pathological Records and Archives, 4 th Edition (2009). 20. SEHSCT Medical Devices Policy 21. SEHSCT Operation Guidelines for Management of Medical Devices 22. SEHSCT ICT Security Policy 23. Point of Care Testing Cholesterol Testing. Medicines and Healthcare products Regulatory Agency, Top 10 Tips. Medicines and Healthcare products Regulatory Agency, CONSULTATION PROCESS SEHSCT POCT committee 9.0 APPENDICES / ATTACHMENTS Appendix 1: Terms of Reference and Membership Appendix 2: Proposal for New or Replacement Point of Care Testing Applications in the South Eastern Health & Social Care Trust Appendix 3: Medical Devices & Equipment Procurement (MD1) Page 7 of 16
8 10.0 EQUALITY STATEMENT In line with duties under the equality legislation (Section 75 of the Northern Ireland Act 1998), Targeting Social Need Initiative, Disability discrimination and the Human Rights Act 1998, an initial screening exercise to ascertain if this policy should be subject to a full impact assessment has been carried out. The outcome of the Equality screening for this policy is: Major impact: Minor impact: No impact: X SIGNATORIES Page 8 of 16
9 Appendix 1: Terms of Reference and Membership Name: Point of Care Testing (POCT) Committee Purpose: The purpose of the committee is to develop and promote patient safety and risk management strategies in the South Eastern Health and Social Care Trust for the safe, effective and efficient utilisation of POCT devices including those given by staff to patients. The Committee is to identify any potential risks or problems associated with POCT devices and ensure risk management is implemented and monitored Roles and responsibilities: This committee shall: Ensure that the responsibilities and authorities necessary for quality management of POCT as defined by CPA (UK) Ltd. and/or UKAS are defined and communicated within the Trust. Assist in evaluating and selecting POCT equipment and systems, using defined healthcare and patient outcomes, consistent with the Regional Policy for POCT Testing in Northern Ireland, the Medical Devices Agency Device Bulletin (MDA DB2002(03)), and the Joint Working Group on Quality Assurance guidelines. Evaluate and approve end-user POCT proposals for the installation of POCT systems. Ensure that appropriate systems are in place for: o Monitoring the training, certification and re-certification of POCT system operators o Maintenance of equipment and supply of consumables and reagents o Appropriate quality assurance and record keeping o Monitoring, review and audit o Security from unauthorised or inappropriate use of POCT devices Provide input for the identification of POCT improvement opportunities, including equipment upgrades and replacement, connectivity options and documentation requirements. Advise changes to POCT policies, processes and procedures when appropriate. Advice on corrective actions required for incidents and alerts relating to the use of POCT systems, as appropriate. Report quarterly to the Women and Acute Child Health Governance meetings on any POCT related governance issues Hold an annual management review of POCT services Membership: This committee shall consist of representatives of the stakeholders for the use of POCT systems. This will include representatives from the laboratory; including POCT Coordinators, laboratory management including quality management; pharmacy, ambulance, IT, risk governance, nursing, infection control, procurement, finance, Medical Technology,, clinicians. Additional members may be co- opted where appropriate. Meetings will be chaired by the laboratory POCT Manager. Meetings will be considered quorate if there are 50% members present. Document approval can take place virtually via . Frequency of meetings: The POCT committee will meet quarterly (minimum 3 meetings per year). Accountability: Page 9 of 16
10 The Chair of the committee will report to the Laboratory Operational Committee, which reports via the Directorate of Women and Acute Child Health to the senior management of the Trust. The committee reports quarterly to the Women and Acute Child Health Governance meetings on any POCT related governance issues Communication: The POCT committee will circulate minutes of its meetings as soon as possible after meetings to the committee membership. Reports will be to laboratory management for the annual management review. The Chair of the committee and POCT Co-ordinators will attend The NI regional POCT committee. Page 10 of 16
11 Appendix 2: Proposal for New or Replacement Point of Care Testing Applications in the South Eastern Health & Social Care Trust PROPOSAL FOR NEW OR REPLACEMENT POINT OF CARE TESTING APPLICATIONS IN THE SOUTH EASTERN HEALTH & SOCIAL CARE TRUST Introduction The South Eastern Health & Social Care Trust (SET) policy for Point of Care Testing (POCT) describes the principles of how the Trust will discharge its responsibilities with regard to the governance of POCT. One important aspect of this is the role of the POCT committee in assessing new and existing POCT applications within the Trust. Scope and Purpose This checklist is intended to prompt consideration of the various elements required for a new or replacement POCT application in order that the POCT committee can assess compliance with Trust policy and relevant guidelines. The information supplied should be supported if possible by additional literature from peer reviewed publications and suppliers. It is recommended that the SET POCT policy and referenced POCT guidelines are reviewed and appropriate Laboratory specialists consulted in completing this pro forma. 1. BASELINE INFORMATION Proposed Location of Testing: Clinical Speciality: Analyte(s) or Test(s) Proposed Purpose of Test Diagnosis, screening, monitoring (disease or treatment) Specimen Requirements (circle): Whole blood Serum Plasma Urine Other: Patient Groups to which POCT would be Applicable: Estimated Test Numbers: Daily: Weekly: Describe briefly the current limitations of the conventional laboratory service for the proposed testing: Confirm that the relevant Laboratory discipline is unable to meet clinical or operational requirements for the proposed testing: 2. OBJECTIVES Summarise the main objectives for the POCT service and how it will impact on patient care: Turnaround time of current test: 3. TESTING (Indicate how the following task will be addressed) Testing: Training: Competency Testing: Maintenance: Page 11 of 16
12 Reagent storage Risk Assessment: Adverse Incident Reporting: Control of Infection: Quality Assurance: Audit: Record Keeping, including competencies: Troubleshooting: 4. ACCOMMODATION Candidate Instrument: Operator Space Required: Storage Space for Device(s), Consumables and Reagents: Services Required (i.e. power, water, refrigeration, etc.): Health & Safety / Control of Infection Issues: 5. COSTS (Approximate) Has recurrent funding been identified? Initial Purchase Cost: Consumables Cost: IT & Other Installation Costs: Internal Quality Control Costs: External Quality Assurance Costs: Audit Costs: Maintenance/Service Contract: Waste Disposal Costs: Laboratory Costs: Pharmacy Costs: Portable: Yes / No If No, i.e. Static (give footprint): Will Pharmacy store reagents? Yes / No If Yes, please give source: Signed Consultant Date Assistant director Date Page 12 of 16
13 Appendix 3: Medical Devices & Equipment Procurement (MD1) Medical Devices & Equipment Procurement MD1 Request for purchase 1) Location Directorate Department Contact name to be Used by purchasing 2) Equipment Description of equipment Estimated cost of equipment 3) Finance Funding method Capital/E&G put in full then abbreviate/ other Procurement complies with Standing financial instructions 4) Procurement method Standardisation Fast Track < 2,000 Procurement Group > 2,000 Pre purchase check list has been completed and is attached No Yes If no why Approved by Assistant Director Signature Page 13 of 16
14 Date Requisition Number Pre purchase checklist Consideration has been given to Trust standardisation and staff training Discussion has taken place with estates regarding accommodation of equipment Consideration has been given to the full life cost of equipment E.g. Service costs, maintenance, consumables Consideration has been given to type or method of decontamination MD1 Is a formal maintenance contract required? If after sales service is needed has due regard been given to who will carry this out? Is the equipment part of a wider project that has cost implications, if so have these been taken into account? E.g. Building, flooring, engineering works Yes No N/A If POCT Device has approval been obtained from Trust? Yes No N/A POCT committee Checklist completed by Name Designation Signature Date Page 14 of 16
15 For supplies use only Requisition Number Order Number Date Post Purchase check list MD1 Equipment has been delivered intact Yes No Commissioning has been carried out i.e. installation, safety checks Has a WIMS Asset form has been completed to generate an ID number and trigger a service contract at end of warranty Staff training has been commenced or put in place Operator /instruction manuals have been received Has a capital asset form been completed? If replacement has service contract on previous equipment been cancelled? Checklist completed by Name Designation Signature Date Requisition Number Order Number * This form is to be attached to the blue buying order Page 15 of 16
16 Customer Care Where page 3 of MD1 is attached to blue receipt copy of order, completion and sign off is required before goods are receipted. Confirmed by Name Designation Signature Date Page 16 of 16
Dominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary
POINT OF CARE TESTING (POCT) IN CRITICAL CARE Authors: Dominic Cox Royal Free Hospital London Joan Pearson Leeds General Infirmary In collaboration with ICS standards committee Introduction Point of Care
More informationGuidance on Quality Management in Laboratories
Guidance on Quality Management in Laboratories series QULAITY IBMS 1 Institute of Biomedical Science Guidance on Quality Management in Laboratories As the UK professional body for biomedical science the
More informationSTANDARDS Point-of-Care Testing
STANDARDS Point-of-Care Testing For Surveys Starting After: January 1, 2018 Date Generated: January 12, 2017 Point-of-Care Testing Published by Accreditation Canada. All rights reserved. No part of this
More informationPOL:00:QP:001:03:NIBT PAGE 1 of 8. Document Details Document Number: POL:00:QP:001:03:NIBT No. of Appendices: 1 Supersedes Number: 00:02:QP:001:NIBT
POL:00:QP:001:03:NIBT PAGE 1 of 8 Northern Ireland Blood Transfusion Service POLICY DOCUMENT Document Details Document Number: POL:00:QP:001:03:NIBT No. of Appendices: 1 Supersedes Number: 00:02:QP:001:NIBT
More informationStandards for Laboratory Accreditation
Standards for Laboratory Accreditation 2017 Edition cap.org 2017 College of American Pathologists. All rights reserved. [ T y p e t h e c o m p a n y a d d r e s s ] CAP Laboratory Accreditation Program
More informationJob Description. TDL Laboratory Staff, Clients and Customers, Group Blood Transfusion Manager
Job Description Job Title: Location: Reporting to: Accountable to: Liaises with: Senior Biomedical Scientist (Blood Transfusion) BMI London Independent Pathology Lead Group Laboratory Director Regional
More informationStandards for the Medical Laboratory
Clinical Pathology 21-47 High Street Feltham Middlesex TW13 4UN Registered in England & Wales No. 2675095 Tel: (020) 8917 8400 Fax: (020) 8917 8500 e-mail: office@cpa-uk.co.uk www.cpa-uk.co.uk Clinical
More informationFor an informal discussion, please contact Geoff Day, Laboratory Manager on or
Biomedical Scientist Specialist Microbiology Band 6 Full Time - 37.5 hours per week Salary Range 25,528-34,189 per annum Relocation Assistance of up to 8000 available Are you looking for a new challenge?
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Routine Project Audit SOP Number: 6 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationMEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS Memorandum of understanding between MHRA, COREC and GTAC
MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Memorandum of understanding between MHRA, COREC and GTAC 1. Purpose and scope 1.1 Regulation 27A of the Medicines for Human Use (Clinical Trials)
More informationSUP 08 Operational procedures for Medical Gas Pipeline Systems (MGPS) Unified procedures for use within NHS Scotland
SUP 08 Operational procedures for Medical Gas Pipeline Systems (MGPS) Unified procedures for use within NHS Scotland May 2015 Contents Page Acknowledgements... 4 Introduction... 5 1. Aim and scope... 6
More informationPathology Quality Review : Outcomes and Update
Pathology Quality Review : Outcomes and Update Dr Ian Barnes UK NEQAS (H) 17 th Annual Meeting National Motorcycle Museum Tuesday 14 th October, 2014 The Review Launched January 28 th, 2014. (england.pathqareview@nhs.net)
More informationAppendix 1 MORTALITY GOVERNANCE POLICY
Appendix 1 MORTALITY GOVERNANCE POLICY 1 Policy Title: Executive Summary: Mortality Governance Policy For many people death under the care of the NHS is an inevitable outcome and they experience excellent
More informationQC Explained Quality Control for Point of Care Testing
QC Explained 1.0 - Quality Control for Point of Care Testing Kee, Sarah., Adams, Lynsey., Whyte, Carla J., McVicker, Louise. Background Point of care testing (POCT) refers to testing that is performed
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Ventilation Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Ventilation Policy Version.: 1.0 Effective From: 15 January 2016 Expiry Date: 15 January 2019 Date Ratified: 22 December 2015 Ratified By: Estates
More informationHEALTH AND SAFETY POLICY
NHS GREATER GLASGOW AND CLYDE HEALTH AND SAFETY POLICY November 2015 Lead Manager: K. Fleming Head of Health and Safety Responsible Director A. MacPherson Director of Human Resources and Organisational
More informationRG 103 Accreditation for the Inspection of Electrical Equipment in Quarries
This publication contains policy, recommendations and guidance applicable to UKAS accredited inspection bodies RG 103 Accreditation for the Inspection of Electrical Equipment in Quarries Contents Section
More informationSTANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice
STANDARD OPERATING PROCEDURE SOP 715 Principles of Clinical Research Laboratory Practice Version 1.2 Version date 13.11.2015 Effective date 24.04.2017 Number of pages 9 Review date June 2018 Author Role
More informationDecontamination of Medical Devices:
Decontamination of Medical Devices: a development plan for healthcare organisations January 2016 Crown copyright 2016 WG27312 Digital ISBN 978 1 4734 5431 6 Foreword Eliminating preventable healthcare
More informationDelegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers. Version No.1 Review: November 2019
Livewell Southwest Delegation to Band 3 and 4 Nursing Unregistered Support Workers Guidance for Staff and Managers Version No.1 Review: November 2019 Notice to staff using a paper copy of this guidance
More informationDecontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation
Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation Version 4.0 Date to be reviewed January 2020 To be reviewed by Medical Engineering Manager Policy Title: Decontamination
More informationJob Description. Senior Biomedical Scientists & Head and Deputy Head of Department. Head of Department (Biochemistry) & Blood Sciences Manager
Job Description Job Title: Location: Reporting to: Accountable to: Biomedical Scientist Clinical Biochemistry Northwick Park & Central Middlesex Hospitals Senior Biomedical Scientists & Head and Deputy
More informationDocument Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026
Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026 Version: 1.1 Ratified by: Committee Date ratified: 03/10/2017 Name of originator/author: Directorate: Department:
More informationStandard Operating Procedures (SOP) Research and Development Office
Standard Operating Procedures (SOP) Research and Development Office Title of SOP: Principles of Data Collection and Storage SOP Number: 8 Supercedes: 1.0 Effective date: August 2013 Review date: August
More informationMedicines Management Policy
Medicines Management Policy Name of Policy: Purpose of Policy: Directorate responsible for Policy Name & Title of Author: Medicines Management Policy The Southern HSC Trust recognises that almost all patients
More informationStandards for Forensic Drug Testing Accreditation
Standards for Forensic Drug Testing Accreditation 2013 Edition cap.org Forensic Drug Testing Accreditation Program Standards for Accreditation 2013 Edition Preamble Forensic drug testing is a laboratory
More informationResearch Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004
Title: Outcome Statement: Research Auditing and Monitoring Procedures Researchers in the Trust and research partners will be informed about the requirements and procedures involved in research audit and
More informationSupervision of Biomedical Support Staff (Assistant and Associate Practitioners)
Supervision of Biomedical Support Staff (Assistant and Associate Practitioners) series IBMS 1 Institute of Biomedical Science Supervision of Biomedical Support Staff (Assistant and Associate Practitioners)
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationspecialising in maths and computing Health, Safety and Environmental Policy Date March 2012 Review Date March 2014 Governor Committee Health & Safety
specialising in maths and computing Health, Safety and Environmental Policy Date March 2012 Review Date March 2014 Governor Committee Health & Safety HEALTH, SAFETY AND ENVIRONMENTAL POLICY HEALTH AND
More informationElmarie Swanepoel 24 th September 2017
MEDICAL EQUIPMENT TRAINING POLICY Policy Register No: 10010 Status: Public Developed in response to: Best practice Contributes to CQC Regulation: 15 Consulted With: Post/Committee/Group: Date: Medical
More informationBlood Transfusion Policy. Version Number: 6.1 Controlled Document Sponsor: Controlled Document Lead: On: December 2014.
Blood Transfusion Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Clinical The policy describes the framework and principles required to deliver best transfusion
More informationRG 102 Accreditation for the Inspection of Non-public High Voltage Electrical Systems
This publication contains policy, recommendations and guidance applicable to UKAS accredited inspection bodies RG 102 Accreditation for the Inspection of Non-public High Voltage Electrical Systems Contents
More informationCAP Forensic Drug Testing Accreditation Program Standards for Accreditation
CAP Forensic Drug Testing Accreditation Program Standards for Accreditation Preamble Forensic drug testing is a laboratory specialty concerned with the testing of urine, oral fluid, hair, and other specimens
More informationWHTM Decontamination of linen for health and social care. Guidance for linen processors implementing BS EN 14065
WHTM 01-04 Welsh Health Technical Memorandum Decontamination of linen for health and social care Guidance for linen processors implementing BS EN 14065 Disclaimer The contents of this document are provided
More informationPOINT OF CARE TESTING POLICY Page 1 of 6 Reviewed: October 2017
Page 1 of 6 Policy Applies to: All clinical staff involved in using Point of Care Testing (POCT) equipment. Related Standards: Health & Disability Standard 4.2.3 Amenities, fixtures, equipment and furniture
More informationStandard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research
Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research For Completion by SOP Author Reference Number PHT/RDSOP/006 Version V1.1 07 Apr 2016 Document Author(s) Document
More informationPOLICY ON THE CONTROL OF ASBESTOS AT WORK
POLICY ON THE CONTROL OF ASBESTOS AT WORK Review date: 27/10/2018 Reviewer: Compliance Officer Circulation for comment: Technical Services Manager Works Supervisor Building Supervisor Data Coordinator
More informationMedical Devices Management Policy
Medical Devices Management Policy Document Reference Document Status POL025 Version: V2.0 Approved DOCUMENT CHANGE HISTORY Initiated by Date Author (s) 20 May 2015 Richard Kirk Version Date Comments (i.e.
More informationReview of Management Arrangements within the Microbiology Division Public Health Wales NHS Trust. Issued: December 2013 Document reference: 653A2013
Review of Management Arrangements within the Microbiology Division Public Health Issued: December 2013 Document reference: 653A2013 Status of report This document has been prepared for the internal use
More informationEuropean Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications
European Reference Networks Guidance on the recognition of Healthcare Providers and UK Oversight of Applications NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients
More informationHealth and Safety Policy and Managerial Responsibilities
Health and Safety Policy and Managerial Responsibilities 1.0 Purpose This document outlines the policies, procedures and practices governing the manner in which the Royal Conservatoire of Scotland manages
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Interim Process and Methods of the Highly Specialised Technologies Programme
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Principles Interim Process and Methods of the Highly Specialised Technologies Programme 1. Our guidance production processes are based on key principles,
More informationEQuIPNational Survey Planning Tool NSQHSS and EQuIP Actions 4.
Standard 1: Governance for safety and Quality and Standard 2: Partnering with Consumers Section 1 Governance, Policies, Business decision making, Organisational / Strategic planning, Consumer involvement
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationBurton Hospitals NHS Foundation Trust. On: 25 January Review Date: December Corporate / Directorate. Department Responsible for Review:
POLICY DOCUMENT Burton Hospitals NHS Foundation Trust MEDICAL DEVICES TRAINING POLICY Approved by: Trust Executive Committee On: 25 January 2017 Review Date: December 2019 Corporate / Directorate Clinical
More informationDate ratified November Review Date November This Policy supersedes the following document which must now be destroyed:
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy
More informationPolicy for Radiographer Reporting of Plain Images
FOR DECISION AGENDA ITEM 15.7 of Plain Images 17 August 2010 Report of Medical Director Paper prepared by Purpose of Paper Action/Decision required Link to Health Care Standards: Link to Health Board s
More informationHertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust
Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust STANDARD OPERATING PROCEDURE FOR RESEARCH THE START UP PROCEDURE FOR RESEARCH STUDIES
More informationPolicy for the use of Leave under Section 17 of the Mental Health Act 1983 (as amended) Version: 9
SH CP 52 Policy for the use of Leave under Section 17 of the Mental Health Act 1983 (as amended) Version: 9 Summary: Keywords (minimum of 5): (To assist policy search engine) Target Audience: Policy for
More informationASBESTOS MANAGEMENT POLICY
ASBESTOS MANAGEMENT POLICY Version 5.0 File ref ASBESTOS MANAGEMENT POLICY Date approved June 2016 Date to be reviewed June 2019 To by reviewed by ASBESTOS STEERING GROUP Asbestos Management Policy June
More informationGuide to Incident Reporting for In-vitro Diagnostic Medical Devices
Guide to Incident Reporting for In-vitro Diagnostic Medical Devices SUR-G0004-4 02 AUGUST 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes
More informationNon Medical Prescribing Policy
Non Medical Prescribing Policy Author: Sponsor/Executive: Responsible committee: Ratified by: Consultation & Approval: (Committee/Groups which signed off the policy, including date) This document replaces:
More informationMedical Devices Policy
Medical Devices Policy Who Should Read This Policy Target Audience All Clinical Staff Version 1.0 December 2015 Ref. Contents Page 1.0 Introduction 4 2.0 Purpose 4 3.0 Objectives 4 4.0 Process 5 4.1 5.0
More informationTITLE: POINT OF CARE TESTING
San Francisco General Hospital and Trauma Center Administrative Policy Policy Number: 16.20 TITLE: POINT OF CARE TESTING DEFINITIONS 1. Point of Care Testing (POCT) refers to laboratory testing performed
More informationPoint of Care Quality Management. Procedure. Approving Authority: President and CEO, Keith Dewar
Subject/Title Point of Care Quality Management Procedure Approving Authority: President and CEO, Keith Dewar Manual: Reference Number: 812-1 Effective Date: Dec 6 th, 2016 Revision Dates: Classification:
More informationRecord Keeping - Legal and Ethical Core CPD
Record Keeping - Legal and Ethical Core CPD Aims: This article provides information about record keeping and the legal aspects relating to record keeping; details about CQC requirements for record keeping;
More informationWrittle College Health and Safety Policy
Writtle College Health and Safety Policy 2015-2016 Document Ownership: Role Title: Chair of the Board Department Approved by Senior Management Team 11 August 2015 Approved by Personnel & Remuneration Committee
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationMHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager
MHRA Findings Dissemination Joint Office Launch Jan. 2012 Presented by: Carolyn Maloney UHL R&D Manager Purpose of presentation To feed back abridged findings from March 2011 MHRA Statutory Systems Inspection
More informationVersion Number: 004 Controlled Document Sponsor: Controlled Document Lead:
Chief Investigators and Principal Investigators in Research Policy CONTROLLED DOCUMENT CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Policy Governance To set out the responsibilities of
More informationDepartment of Agriculture, Environment and Rural Affairs (DAERA)
Department of Agriculture, Environment and Rural Affairs (DAERA) Guidance for the implementation of LEADER Cooperation activities in the Rural Development Programme for Northern Ireland 2014-2020 Please
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationHEALTH and SAFETY POLICY
HEALTH and SAFETY POLICY Version 5 March 2016 (review & minor amendments October 14 & March 2016) Approved by the Executive/SLT on: May 2012 Staff Consultative Group advised on: June 2012 Board of Governors
More informationLaboratory Assessment Tool
WHO/HSE/GCR/LYO/2012.2 Laboratory Assessment Tool Annex 1: Laboratory Assessment Tool / System Questionnaire April 2012 World Health Organization 2012 All rights reserved. The designations employed and
More informationHEALTH AND SAFETY POLICY 2010
April 2008 CONTENTS Page No ii 1 GENERAL STATEMENT OF POLICY 2 2 DELIVERING HEALTH AND SAFETY 3 2.1 Management 3 2.2 Policy and Procedures 3 2.3 Training 4 2.4 Communication and Involvement 4 2.5 The Working
More informationQUALITY POLICY MANUAL. Revision: 05 Author: T. Joseph Issue Date: 6/6/2010 Approved By: Dr S. King
This document together with the procedures specified in this manual, represent the quality management system of Laboratory Services & Consultations Ltd. It has been complied to meet the requirement of
More informationNORTHERN IRELAND LOCAL ENHANCED SERVICE PRIMARY CARE OPTOMETRY. Intra Ocular Pressure Repeat Measures (Level I LES)
NORTHERN IRELAND LOCAL ENHANCED SERVICE PRIMARY CARE OPTOMETRY Intra Ocular Pressure Repeat Measures (Level I LES) COMMENCED 1 ST DECEMBER 2013 (SERVICE SPECIFICATION UPDATED FEBRUARY 2018) INTRODUCTION
More informationEstates Operations and Maintenance Practice Guidance Note Pest Control V01. Planned Review November Contents. Section Description Page No
Estates Operations and Maintenance Practice Guidance Note Pest Control V01 Date Issued Issue 1 November 2016 Issue 2 November 2017 Planned Review November 2019 E-PGN-34 Part of NTW(O)32 Estates Operations
More informationDocument Title: Document Number:
including Document Title: Document Number: Version: 2.0 Ratified by: Committee Date ratified: 25/01/2018 Name of originator/author: Directorate: Department: Name of responsible individual: Rachel Fay Corporate
More informationHealth and Safety Policy
Health and Safety Policy 2015 Statement of Health and Safety Policy The University recognises its obligations to properly control the risks to the health of its staff, students and visitors. Strong strategic
More informationSTANDARD OPERATING PROCEDURE
STANDARD OPERATING PROCEDURE Title Reference Number Sponsorship SOP-RES-001 Version Number 3 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s) Teresa
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Central Alert System (CAS) Policy and Procedure
The Newcastle upon Tyne Hospitals NHS Foundation Trust Central Alert System (CAS) Policy and Procedure Version No.: 4.1 Effective From: 6 August 2013 Expiry Date: 6 August 2016 Date Ratified: 2 August
More informationTrial Management: Trial Master Files and Investigator Site Files
Title: Outcome Statement: Written By: Trial Management: Trial Master Files and Investigator Site Files Staff working on research studies in NSFT will be informed about the requirements of setting up and
More informationGuidance for MRC units on HTA licence applications for storage of human samples for research purposes
Guidance for MRC units on HTA licence applications for storage of human samples for research purposes Summary In England, Wales and Northern Ireland the Human Tissue Authority (HTA) is licensing premises
More informationASBESTOS POLICY. Version: 3 Senior Managers Operational Group Date ratified: March 2016
ASBESTOS POLICY Version: 3 Ratified by: Senior Managers Operational Group Date ratified: March 2016 Title of originator/author: Estates Manager Title of responsible committee/group: Regulation Governance
More informationCLOZAPINE ONE STOP CLINIC POLICY (SANDWELL) Revised
1.18 CLOZAPINE ONE STOP CLINIC POLICY (SANDWELL) Policy Title State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies only - state index category
More informationMoving and Handling Policy
Moving and Handling Policy Ratified Status Approved Final Issued 28 April 2016 Approved By Quality, Patient Safety and Risk Committee Consultation Executive Committee Equality Impact Assessment Embedded
More informationHEALTH AND SAFETY POLICY
Reference Number: UHB 021 Version Number: 4 Date of Next Review: 24 Nov 2019 Previous Trust/LHB Reference Number: T29 HEALTH AND SAFETY POLICY Statement On behalf of Cardiff and Vale University Local Health,
More informationDo Not Attempt Resuscitation Policy
Do Not Attempt Resuscitation Policy PROV 27 March 2009 1 Document Management Title of document Do Not Attempt Resuscitation Policy Type of document Policy PROV 27 Description To ensure that do not resuscitate
More informationOxfordshire Primary Care Commissioning Committee
Oxfordshire Clinical Commissioning Group Oxfordshire Primary Care Commissioning Committee Date of Meeting: 2 May 2017 Paper No: 15 Title of Paper: Memorandum of Understanding (MOU) for Primary Medical
More informationMoving and Handling Policy
Moving and Handling Policy Ratified Quality, Patient Safety and Risk / 16/04/2014 / 2014-40 Status Ratified Issued April 2014 Approved By Quality, Patient Safety and Risk Committee Consultation Quality,
More informationStandard Operating Procedure (SOP) Research and Development Office
Standard Operating Procedure (SOP) Research and Development Office Title of SOP: Delegated Responsibilities in Research Projects SOP Number: 11 Version Number: 2.0 Supercedes: 1.0 Effective date: August
More informationStandard Operating Procedure Research Governance
Research and Enterprise Standard Operating Procedure Research Governance Title: Research Governance Audit SOP Reference Number: QUB-ADRE-08 Date prepared 7 August 008 Version Number: Final v -6.0 Revision
More informationSTANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager
STANDARD OPERATING PROCEDURE SOP 710 Good Clinical Practice AUDIT AND INSPECTION Version 1.3 Version date 27.02.2018 Effective date 3.03.2018 Number of pages 10 Review date February 2020 Author Role Approved
More informationNational policy for nurse and midwife medicinal product prescribing in primary, community and continuing care
National policy for nurse and midwife medicinal product prescribing in primary, community and continuing care Item type Authors Publisher Report Health Service Executive (HSE) Office of the Nursing Services
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationGENERAL HEALTH AND SAFETY POLICY
GENERAL HEALTH AND SAFETY POLICY 2017-18 GENERAL STATEMENT OF INTENT Moreton Hall is committed to ensuring the health and well being of its students, staff and visitors, so far as is reasonably practicable.
More informationTHE CODE. Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland. Effective from 1 March 2016
THE CODE Professional standards of conduct, ethics and performance for pharmacists in Northern Ireland Effective from 1 March 2016 PRINCIPLE 1: ALWAYS PUT THE PATIENT FIRST PRINCIPLE 2: PROVIDE A SAFE
More informationOrganisation of a Clinical Laboratory. Peter O Loughlin SA Pathology
Organisation of a Clinical Laboratory Peter O Loughlin SA Pathology AACB Curriculum 5. Laboratory Management (a) Organisation of a Clinical Laboratory (FAACB) Hospital Management Structure and the Clinical
More informationMedical Devices Policy
Medical Devices Policy This policy describes the process for the management of medical devices. Key Words: Medical Devices, Medical Equipment Version: 6 Adopted by: Quality Assurance Committee Date adopted:
More informationFacilities and Estates. Safety and Suitability of Premises Policy. Document Control Summary. Contents. New. Status:
Facilities and Estates Safety and Suitability of Premises Policy Document Control Summary Status: New Version: v1.0 Date: 29/1/2016 Author/Title: Owner/Title: Simon Davidson Assistant Director of Facilities
More informationRD SOP12 Research Passport Honorary Contracts / Letters of Access
RD SOP12 Research Passport Honorary Contracts / Letters of Access Version Number: V2.1 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive
More informationHealth and Safety Roles and. Responsibilities SI0317
SI Identification Number Policy Ownership SI0317 Chief Health and Safety Adviser Issue Date 19/01/2017 Review Date Governing Service Policy Cancellation of Classification Annually Health & Safety SP01/2013
More informationMedical Devices Management Policy
Document Author Written By: Medical Devices Co-ordinator Date: 07/02/17 Lead Director: Exectuve Director of Nursing & Quality Authorised Authorised By: Chief Executive Date: 11/04/2017 Effective Date:
More informationCompetencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification
Competencies for NHS Health Check Enhanced Service using the General Level Framework & Service Specification This is a comprehensive mapping of the GLF against the enhanced service specification (where
More informationPart A: practice organization Part B: practice management Part C: pharmacy Part D: medical records Part E: investigations
for 2017 and 2018 candidates Luk Kam Hung 30 January 2016 Three out of Four segments: Clinical Audit or Research Consultation Skill Assessment Practice Assessment Please check the College website/ FP links
More informationLABORATORY USER SATISFACTION SURVEY
Approver: Raymond Gamble Page 1 of 12 1. INTRODUCTION LABORATORY USER SATISFACTION SURVEY The Laboratory recognises that in order to achieve continual quality improvement, any feedback from its service
More information2. The main aims of the implementation facilitator role can be captured by the following objectives:
NICE in Northern Ireland Implementation Facilitator Engagement Activities 2013/14 Executive Summary 1. From 1 October 2012, NICE was able to secure funding, after negotiations with the Department of Health,
More information